StonvexLoading…
StonvexCore line items from BMNM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $5.13M | $16.58M | $11.85M | $7.39M |
Operating Income | $1.02M | $4.49M | $2.98M | $782.68K |
Net Income | $801.05K | $5.80M | $2.42M | $42.73K |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $58.45M | $129.69M | $139.75M | $138.75M |
Total Liabilities | $45.03M | $117.07M | $130.51M | $131.33M |
Cash & Equivalents | $16.38M | $12.70M | $9.56M | $5.34M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available |